PF-Atlas › Clinical Trials › NCT01346930
Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Macitentan · Phase 2
Registry ID
NCT01346930
Phase
Phase 2
Status
Withdrawn
Drug / intervention
Macitentan
Sponsor
Actelion
Start
2011-07-31
About this trial
The MUSIC OL study is an open-label extension study, in which all eligible patients having completed the double-blind AC-055B201/MUSIC study as scheduled receive macitentan 10 mg once daily. The study objective is to assess the long-term safety and tolerability of macitentan in patients with idiopathic pulmonary fibrosis (IPF).
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01346930 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.